0001437749-20-000323.txt : 20200107
0001437749-20-000323.hdr.sgml : 20200107
20200107200451
ACCESSION NUMBER: 0001437749-20-000323
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200102
FILED AS OF DATE: 20200107
DATE AS OF CHANGE: 20200107
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LIU VIVIAN H
CENTRAL INDEX KEY: 0001203467
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-52991
FILM NUMBER: 20514354
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: INNOVUS PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001411879
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 900814124
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 8845 REHCO ROAD
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-964-5123
MAIL ADDRESS:
STREET 1: 8845 REHCO ROAD
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
FORMER COMPANY:
FORMER CONFORMED NAME: North Horizon, Inc.
DATE OF NAME CHANGE: 20070910
4
1
rdgdoc.xml
FORM 4
X0306
4
2020-01-02
0001411879
INNOVUS PHARMACEUTICALS, INC.
INNV
0001203467
LIU VIVIAN H
8845 REHCO ROAD
SAN DIEGO
CA
92121
1
Restricted Stock Units
2020-01-02
4
A
0
10112
0.89
A
2020-01-02
2030-01-02
Common Stock
10112
42902
D
Each restricted stock unit represents the contingent right to receive, at settlement, one share of common stock.
The Reporting Person was granted a Restricted Stock Unit on January 2, 2020 of 10,112 shares, which were fully vested on the date of the grant. The RSU is for the Reporting Person's quarterly compensation as a member of the Board of Directors for the fourth quarter of 2020 and was valued on December 31, 2019 in accordance with the approved compensation plan for the non-employee members of the Board of Directors.
These restricted stock units were granted pursuant to the Issuer's Amended and Restated 2019 Equity Incentive Plan.
/s/ VIVIAN LIU
2020-01-02